Log in to search using one of your social media accounts:

 

FDA Approves Gene Therapy Tested In Boston To Treat Adults With Lymphoma
TRENTON, N.J. (CBS/AP) — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults. The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy approved in the U.S. in August, a treatment for childhood leukemia from Novartis Pharmaceuticals. That Novartis treatment was tested in Boston. In those tests, Dana Farber and Brigham and Women’s Hospital cancer researchers found that 80 percent of lymphoma patients who underwent the treatmen...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 19, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News blood cancer Brigham and Women's Hospital Dana Farber FDA Gene Therapy Novartis Pharmaceuticals Source Type: news

Nigeria: Nigerian Doctor, Donald Nwosu Battles Deadly Cancer
[This Day] As public health physician, Donald Nwosu battles a rare type of cancer, Non-Hodgkins Lymphoma, Martins Ifijeh chronicles his fight to overcome the deadly disease, adding that he urgently needs help in order to survive it (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 20, 2017 Category: African Health Source Type: news

This 11-Year-Old Is One Of The Youngest Certified Yoga Teachers In America
Tabay Atkins is one of the youngest certified yoga instructors in the country. He received the first of his four yoga certifications just a week before his 11th birthday last August. HuffPost spoke Wednesday with Tabay and his mom, Sahel Anvarinejad, whose battle with cancer first inspired Tabay to get involved with the practice.  Tabay, who is currently on a working vacay in Maui, Hawaii, with his family, was just 6 years old when his mother was diagnosed with Non-Hodgkin’s lymphoma.  In 2012, just two weeks after Anvarinejad’s recovery from the disease ― which hampered her ability to walk, among o...
Source: Healthy Living - The Huffington Post - June 22, 2017 Category: Consumer Health News Source Type: news

Latest Keytruda Approval Promising for Mesothelioma Patients
The U.S. Food and Drug Administration (FDA) expanded its approval of pembrolizumab for first-line treatment of metastatic non-small cell lung cancer last week, moving it closer to becoming a viable treatment option for patients with pleural mesothelioma. Pembrolizumab is marketed by Merck & Co. under the brand name Keytruda. It helps the body’s immune system detect and destroy cancer cells. The FDA approved its first-line use in combination with pemetrexed and carboplatin, two chemotherapy agents used regularly for mesothelioma. Pembrolizumab, the most well-known immunotherapy drug, is being studied for use with...
Source: Asbestos and Mesothelioma News - May 19, 2017 Category: Environmental Health Authors: Matt Mauney Tags: carboplatin chemotherapy for mesothelioma Dr. Raymond Wong Dr. Tawee Tanvetyanon FDA approval Keytruda first line treatment for mesothelioma Hodgkin lymphoma jimmy carter keytruda clinical trial keytruda for mesothelioma melanoma Mer Source Type: news

Moms Exposed To Monsanto Weed Killer Means Bad Outcomes For Babies
Concerns about the world’s most widely used herbicide are taking a new twist as researchers unveil data that indicates pervasive use of Monsanto Co.’s weed killer could be linked to pregnancy problems. Researchers looking at exposure to the herbicide known as glyphosate, the key ingredient in Monsanto’s Roundup-branded herbicides, said they tested and tracked 69 expectant mothers and found that the presence of glyphosate levels in their bodily fluids correlated with unfavorable birth outcomes. The research is still in preliminary stages and the sample size is small, but the team is scheduled to present th...
Source: Healthy Living - The Huffington Post - April 4, 2017 Category: Consumer Health News Source Type: news

Spencer gets back on the court after cancer
For much of his 17 years, Spencer Riley has lived to play basketball. This winter, his favorite sport helped the teenager get back to life. Riley was diagnosed with non-Hodgkin lymphoma in 2016 and treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center that summer. He underwent an intensive three-month treatment cycle: one week of inpatient chemotherapy at Boston Children’s Hospital, two weeks of recuperation at home, and then back to Boston Children’s. While occasionally well enough to go on family outings, he was still too weak to shoot or even dribble a basketball. But the game was ...
Source: Thrive, Children's Hospital Boston - March 29, 2017 Category: Pediatrics Authors: Saul Wisnia Tags: Diseases & Conditions Our Patients’ Stories Dana-Farber/Boston Children's Cancer and Blood Disorders Center Dr. Dan Benedetti non-Hodgkin lymphoma Source Type: news

ICR study reports Hodgkin lymphoma survivors at high risk of second cancers
A new study conducted by UK-based Institute of Cancer Research (ICR) has revealed that Hodgkin lymphoma survivors are at high risk of developing a second type of cancer, especially if they have a family history of the disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 14, 2017 Category: Pharmaceuticals Source Type: news

Hodgkin Lymphoma Survivors Face Risk of Second Cancer
Those diagnosed at younger age or have a family history of cancer even more vulnerable Source: HealthDay Related MedlinePlus Page: Hodgkin Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 13, 2017 Category: Consumer Health News Source Type: news

Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 13, 2017 Category: Science Source Type: news

Hodgkin lymphoma survivors at high risk of second cancers
(Institute of Cancer Research) Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 13, 2017 Category: Cancer & Oncology Source Type: news

UNC Lineberger launches innovative cellular immunotherapy program
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center has opened two cellular immunotherapy trials. The early-stage CAR-T trials are for patients with either Hodgkin lymphoma or non-Hodgkin lymphoma, who lack other treatment options or are at high risk of their disease returning. Researchers are working to open trials for other cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2017 Category: Global & Universal Source Type: news

Africa: Hodgkin's Lymphoma - an Uncommon Cancer That's Easily Missed in Africa
[The Conversation Africa] Hodgkin's lymphoma is an uncommon cancer that targets the immune system. It starts off as a painless swelling in the neck, armpit or groin. The Conversation Africa's health editor Joy Wanja Muraya asked Professor Nicholas Abinya to explain the disease, its stages of development and treatment. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 17, 2017 Category: African Health Source Type: news

Veterans Exposed To Contaminated Water At Marine Base To Receive Disability Benefits
WASHINGTON, Jan 12 (Reuters) - The Obama administration has agreed to provide disability benefits to military veterans exposed to contaminated drinking water while at Camp Lejeune in North Carolina, according to an official notice published on Thursday. Veterans, former reservists and former National Guard members who served for at least 30 days at the U.S. Marine Corps Base from 1953 to 1987 and have been diagnosed with one of eight diseases are eligible, according to the document published in the Federal Register, the government’s official journal. The Associated Press, which first reported the story, said the esti...
Source: Healthy Living - The Huffington Post - January 13, 2017 Category: Consumer Health News Source Type: news

VA ’s Rule Establishes a Presumption of Service Connection for Diseases Associated with Exposure to Contaminants in the Water Supply at Camp Lejeune
The U.S. Department of Veterans Affairs (VA) announced that it has established a presumption of service connection for eight diseases that may be associated with exposure to contamination in the water supply at Camp Lejeune in North Carolina from August 1, 1953 to December 31, 1987. This will make it easier for veterans to receive the care and benefits they need. The eight diseases are adult leukemia, aplastic anemia and other myelodysplatic syndromes, bladder, kidney, or liver cancer, multiple myeloma, non-Hodgkin's lymphoma, and Parkinson's disease. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 13, 2017 Category: Rural Health Source Type: news

Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news

NIAID research aids discovery of genetic immune disorder
(NIH/National Institute of Allergy and Infectious Diseases) NIAID investigators and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma. The researchers studied two unrelated sets of siblings with similar immune problems and determined their symptoms were likely caused by a lack of CD70, a protein found on the surface of several types of immune cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 23, 2016 Category: Cancer & Oncology Source Type: news

Seattle cancer center bets big on experimental T-cell immunotherapy
Suzanne McCarroll, a television news reporter in Denver, had been in remission from non-Hodgkin lymphoma for almost eight years when the cancer returned in May 2015. She had a stem-cell transplant, but the disease came back again in January. What, she wondered, should she do now? After talking to her doctor and her brother, a […]Related:Children’s sleeplessness may be linked to bedtime use of electronic gadgetsOpioid pills ‘are like guns': More than 13,000 children were poisoned during six-year periodNew data shows a deadly measles complication is more common than thought (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 1, 2016 Category: Consumer Health News Source Type: news

September Is Childhood Obesity Month -- Get The Facts
The obesity epidemic continues to dominate headlines--and for good reason. Obesity is a leading cause of heart disease, diabetes, high blood pressure, and stroke. Many of these conditions occur in adults but often begin in childhood. This September is National Childhood Obesity Awareness Month. By knowing the facts and taking steps to help your children live a healthier lifestyle, childhood obesity and its resulting complications may be prevented. The Facts According to the Centers for Disease Control & Prevention (CDC), one in three children in the U.S. is overweight or obese. Childhood obesity doubled in children ...
Source: Healthy Living - The Huffington Post - September 28, 2016 Category: Consumer Health News Source Type: news

Hodgkin Lymphoma Patients Have High Fatigue Levels Regardless of Tumor Stage
Patients with Hodgkin lymphoma have a high incidence of severe acute and persistent fatigue, regardless of their tumor stage or the treatment method chosen for their disease. (Source: CancerNetwork)
Source: CancerNetwork - September 18, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Hematologic Malignancies Leukemia & Lymphoma News Source Type: news

Make the Diagnosis: Mysterious Mass
(MedPage Today) -- Case Findings: A 40-year-old male presents with a painful mass on his left shoulder of 5 months'duration. He has a history of stage IV scleronodular type of Hodgkin's disease that was treated 23 years ago with chemotherapy and radiation therapy. He relapsed a year later, and required another round of chemotherapy followed by autologous hematopoietic stem cell transplantation. He relapsed again the next year, and underwent another chemotherapy regimen and allogeneic stem cell transplantation. He has been disease-free for 20 years. What is your diagnosis? (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 13, 2016 Category: Gastroenterology Source Type: news

Does Roundup Cause Cancer?
It's one thing for a presidential candidate to support and defend a company that is responsible for genetically engineering organisms (GMOs) that have been banned in 38 countries. But it's quite another for a candidate to defend, invest in, or take hundreds of thousands of dollars from a company whose most successful product is the target of lawsuits that claim it causes cancer. Democratic presidential nominee Hillary Clinton has enjoyed a long, profitable relationship with Monsanto. The St. Louis-based agribusiness giant is a world leader in GMOs. It also manufactures Roundup, the popular weed killer that multiple stud...
Source: Healthy Living - The Huffington Post - September 1, 2016 Category: Consumer Health News Source Type: news

Mesothelioma Clinical Trial for Tazemetostat Launches in US
City of Hope cancer center thoracic oncologist Dr. Marianna Koczywas explains the workings of tazemetostat — the latest drug tested in a mesothelioma clinical trial — with the lock and key metaphor. “You have a specific [cancer] key, and a specific keyhole it goes through. If you can lock that keyhole, you can lock it out,” Koczywas told Asbestos.com. “These malignant cells rely on a pathway for growth and division so you try and block that specific pathway.” Koczywas is principal investigator for the mesothelioma clinical trial at the City of Hope National Medical Center in Los Angeles,...
Source: Asbestos and Mesothelioma News - August 31, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: cancer treatment city of hope cancer center clinical trials at memorial sloan kettering clinical trials in california malignant pleural mesothelioma treatment marianna koczywas mesothelioma clinical trial tazemetostat Source Type: news

New PET device could go to your head
Researchers are developing quite the novel way to acquire PET brain scans....Read more on AuntMinnie.comRelated Reading: PET with tau agent sheds light on Alzheimer's disease SNMMI: PET shows tau may be Alzheimer's catalyst SNMMI: PET helps track neuroinflammation in MS FDG-PET helps accurately assess unconscious patients PET obviates toxic chemo for some Hodgkin's patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2016 Category: Radiology Source Type: news

Novel statistical method captures long-term health burden of pediatric cancer cures
( St. Jude Children's Research Hospital ) St. Jude Children's Research Hospital researchers have developed a metric that showed therapy-related cardiovascular disease takes a heavier toll on pediatric Hodgkin lymphoma survivors than previously recognized. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 25, 2016 Category: Cancer & Oncology Source Type: news

Five-year survival data: Brentuximab vedotin may be curative in some with Hodgkin lymphoma
(American Society of Hematology) This multinational Phase II study examines brentuximab vedotin (BV) in patients with Hodgkin lymphoma who relapsed after stem cell transplant. The study reports that 13 of 34 (38 percent) patients who achieved complete remission have remained disease-free for over five years and may be cured. Of those patients, nine received only single-agent BV. These data were published in Blood, the journal of the American Society of Hematology (ASH). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 18, 2016 Category: Global & Universal Source Type: news

Non-Hodgkin's Lymphoma
Title: Non-Hodgkin's LymphomaCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/14/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 14, 2016 Category: Cancer & Oncology Source Type: news

Nearly 1 in 12 patients with a common cancer develop a second, unrelated malignancy
UCLA researchers have identified the incidence and long-term outcomes of patients who develop second, unrelated cancers, resulting in a data set that they say sheds new light on the way cancer survivors may need to be monitored post-disease. The researchers identified more than 2.1 million patients from the Surveillance, Epidemiology and End Results database, or SEER, with the most common cancers — prostate, breast, lung, colon, rectum, bladder, uterus, kidney and melanoma and non-Hodgkin lymphoma. The team found that 8 percent of patients developed secondary cancers elsewhere, the most common of which was lung cance...
Source: UCLA Newsroom: Health Sciences - July 13, 2016 Category: Universities & Medical Training Source Type: news

What Are The Most Common Pediatric Cancers?
Discussion Cancer occurs in all ages including children. Fortunately cancer is much less common in the pediatric age group accounting for
Source: PediatricEducation.org - July 4, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Finding A Cure Wouldn’t Mean We’ve Defeated Cancer
WebMD wasn't a research option when Ivy Brown was diagnosed with Hodgkin's lymphoma in 1974, so her mother looked up her 12-year-old daughter's condition the old-fashioned way, in a hardcover medical volume. "It just said 'fatal,'" Brown explained. Having moved the family to London a month earlier, Brown's parents were still trying to liaise with her pediatrician in the U.S. "My father told me recently that he was sleeping with the phone on his stomach because of the time change," she said. "They were as scared as you can be when you have a child who you think you might lose," Brown explained....
Source: Science - The Huffington Post - June 29, 2016 Category: Science Source Type: news

Finding A Cure Wouldn’t Mean We’ve Defeated Cancer
WebMD wasn't a research option when Ivy Brown was diagnosed with Hodgkin's lymphoma in 1974, so her mother looked up her 12-year-old daughter's condition the old-fashioned way, in a hardcover medical volume. "It just said 'fatal,'" Brown explained. Having moved the family to London a month earlier, Brown's parents were still trying to liaise with her pediatrician in the U.S. "My father told me recently that he was sleeping with the phone on his stomach because of the time change," she said. "They were as scared as you can be when you have a child who you think you might lose," Brown explained....
Source: Healthy Living - The Huffington Post - June 29, 2016 Category: Consumer Health News Source Type: news

When Parents Get Cancer, Children Are Often The Forgotten Victims
On the first day of spring 2007, Francesca Giessmann, 43, a marketing executive and holistic health coach from Kirkland, Washington, was rushed to the emergency room with severe stomach pain. After running numerous tests, doctors gave her the diagnosis of stage 3 non-Hodgkin lymphoma. Shocked and saddened by the news of her cancer, Giessmann's thoughts quickly turned to her son, Leo, who'd turned 3 years old the month prior. "Leo was very young and could not fully understand what was going on," Giessmann said. "Our pediatrician suggested we try to keep everything normal. I spent a great deal of time in be...
Source: Healthy Living - The Huffington Post - June 29, 2016 Category: Consumer Health News Source Type: news

Scans May Spare Some Hodgkin Lymphoma Patients from Chemo
Test finds those who might respond well, may spare others treatment side effects Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Hodgkin Disease, Nuclear Scans (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 23, 2016 Category: Consumer Health News Source Type: news

Increase in obesity among pediatric Hodgkin Lymphoma patients may be linked to disease relapse
A new study used advanced imaging methods to evaluate obesity, and suggests a relationship between obesity and disease relapse. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 6, 2016 Category: Science Source Type: news

What REALLY Went Down at Stomp The Monster, the Event to Help Cancer Patients and Their Families
Stomp the Monster 5k Run and Festival 2016. Video of some runners. Stomp the Monster Website & Twitter. Photo by Lisa Lewis. You know how I love to write about events that are kid friendly? Well, that's because I'd rather write than learn how to cook. Today's adventure was attending the Stomp the Monster 5k Run and Festival. STOMP The Monster™ provides financial and other support to cancer patients, their families, and caregivers when they need it most - during their fight with the disease. They promote a healthy lifestyle with proper diet and exercise, leading by example, and provide funding for potential adv...
Source: Healthy Living - The Huffington Post - June 6, 2016 Category: Consumer Health News Source Type: news

FDA Approves New Immunotherapy Drug for Bladder Cancer
By Hope Cristol The U.S. Food and Drug Administration (FDA) gave accelerated approval to immunotherapy drug Tecentriq (atezolizumab) this week for advanced bladder cancer. It is the first new drug approval in 3 decades for the disease, which is expected to be diagnosed in about 77,000 people in the U.S. in 2016. Tecentriq is part of a new class of immunotherapy drugs called checkpoint inhibitors. This drug, given as an infusion, targets the PD-L1 protein, which some cancer cells use to evade the immune system. By blocking PD-L1, it helps immune cells recognize and attack cancer cells. In a clinical trial that led to the dr...
Source: American Cancer Society :: News and Features - May 20, 2016 Category: Cancer & Oncology Tags: Bladder Cancer Source Type: news

FDA Approves Opdivo for Hard-to-Treat Hodgkin Lymphoma
By Hope Cristol Patients with hard-to-treat Hodgkin lymphoma now have a new treatment option. The U.S. Food and Drug Administration granted accelerated approval to Opdivo (nivolumab) for classic Hodgkin lymphoma that has returned or progressed after a specific type of stem cell transplant and post-transplant medicine. Hodgkin lymphoma is a cancer of the lymph system, which is part of the immune system. There are two main types of this disease, but “classic” Hodgkin lymphoma accounts for about 95% of all cases in developed countries. The American Cancer Society estimates about 8,500 new cases of Hodgkin lym...
Source: American Cancer Society :: News and Features - May 19, 2016 Category: Cancer & Oncology Tags: Hodgkin Disease Source Type: news

Worries Mount Over Potential Link Between Artificial Turf And Cancer
The federal government launched a new effort in February to study health concerns related to synthetic turf, as worries grow about possible cancer risks to the millions of athletes who play on artificial fields across the country. Now, a former top soccer player who helped convince the feds to investigate the issue says more than 200 athletes have reached out to her after being diagnosed with cancer. Amy Griffin, a goalkeeper for the U.S. National team that won the first women’s World Cup in 1991, has been informally tracking American soccer players with cancer since 2009, when she noticed a “stream of kids&rdq...
Source: Science - The Huffington Post - April 14, 2016 Category: Science Source Type: news

NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma—a Rare, Yet Curable, Cancer
New patient education resources from NCCN empower patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma to work alongside their physicians to make informed decisions about their treatment. FORT WASHINGTON, PA - To further educate people with Chronic Lymphocytic Leukemia (CLL) and Hodgkin Lymphoma about the most effective treatment options for their disease, the National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ series... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 3, 2016 Category: Cancer & Oncology Source Type: news

New Cancer Therapy Could Give Hope To 'Incurable' Patients
A new experimental treatment has achieved what chemotherapy and bone marrow transplants have failed to do: put chronic, relapsing blood cancers into remission. What's more, it uses the body's own natural defense system to attack these cancerous growths.  The treatment involves T cells, a type of immune cell that works as your body's own personal S.W.A.T. team to detect, surround, and destroy foreign invaders like bacteria or viruses. Historically, cancerous cells have grown too fast for T cells to mount an effective defense, and they can also trick T cells into thinking that they’re a healthy part of t...
Source: Science - The Huffington Post - February 17, 2016 Category: Science Source Type: news

FDA to Start Testing for Glyphosate in Food
This article originally appeared on Civil Eats (Source: TIME.com: Top Science and Health Stories)
Source: TIME.com: Top Science and Health Stories - February 17, 2016 Category: Consumer Health News Authors: Carey Gillam / CivilEats.com Tags: Uncategorized Cancer FDA Food glyphosate health Nutrition Pesticide public health Roundup Toxin toxins weed killer Source Type: news

Alzheimer's disease 'wonder drug' claims are premature
ConclusionThe number of people with Alzheimer's disease is increasing as the global population ages. Researchers have estimated 44 million people currently have the condition, and this number will grow to more than 135 million by 2050. It's believed the condition is caused at least in part by the accumulation of toxic aggregates of beta-amyloid protein pieces in the brain. Researchers hope stopping this aggregation could be a way to prevent or treat the disease, but have not yet found successful ways of doing this.This piece of research looked at nerve cells and microscopic worms genetically modified to develop beta-amyloi...
Source: NHS News Feed - February 15, 2016 Category: Consumer Health News Tags: Medication Neurology Older people Source Type: news

The Cancer Moonshot Could Depend Most on You
In his State of the Union address, President Barack Obama announced that Vice President Joe Biden would lead an effort toward a "moonshot" cure for cancer. More recently, Vice President Biden met with health care leaders at the World Economic Forum in Davos to build momentum for the initiative, and later will meet with agency officials and Cabinet members about how the federal government can fund more research and treatment. This is an ambitious task, to say the least, especially for a disease whose "cure" is often regarded as synonymous with an impossible dream. Cancer kills more than half a milli...
Source: Science - The Huffington Post - February 8, 2016 Category: Science Source Type: news

Could IVF Raise Children's Odds for Blood Cancer?
Study of in vitro fertilization shows slightly elevated risk, but experts aren't sounding alarms Source: HealthDay Related MedlinePlus Pages: Assisted Reproductive Technology, Childhood Leukemia, Hodgkin Disease (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 4, 2016 Category: Consumer Health News Source Type: news

Young Black, Hispanic Hodgkin Lymphoma Patients Face Worse Outcomes: Study
Early stage disease can be cured about 90 percent of the time, researchers note (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Research, News, Source Type: news

Young Black, Hispanic Hodgkin Lymphoma Patients Face Worse Outcomes
Early stage disease can be cured about 90 percent of the time, researchers note Source: HealthDay Related MedlinePlus Pages: Health Disparities, Hodgkin Disease, Lymphoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 3, 2016 Category: Consumer Health News Source Type: news

Young Black, Hispanic Hodgkin Lymphoma Patients Face Worse Outcomes: Study
Early stage disease can be cured about 90 percent of the time, researchers note (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 3, 2016 Category: Cancer & Oncology Source Type: news

New Hodgkin's Protocol: Brentuximab Vedotin and NivolumabNew Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab
The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease. Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Lymphoma Survivors May Not Get All Recommended Follow-Up Care
California study finds gaps in after-care for teen and young adult Hodgkin disease survivors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 15, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Family Medicine, Nursing, Oncology, Pediatrics, News, Source Type: news

Lymphoma Survivors May Not Get All Recommended Follow-Up Care
California study finds gaps in after-care for teen and young adult Hodgkin disease survivorsSource: HealthDay Related MedlinePlus Pages: Cancer--Living with Cancer, Lymphoma (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 15, 2016 Category: Consumer Health News Source Type: news